Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
| Image |  |
|---|---|
| Description | scientific article published on 24 April 2017 |
| Author/s |
author: Christopher B. Granger Giuseppe Boriani Renato Delascio Lopes A Marco Alings A. John Camm Stefan H Hohnloser |
| Publication date | April 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |